SlateStone Wealth LLC Buys 138 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

SlateStone Wealth LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 4,176 shares of the medical equipment provider’s stock after acquiring an additional 138 shares during the quarter. SlateStone Wealth LLC’s holdings in Intuitive Surgical were worth $2,180,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Massachusetts Financial Services Co. MA acquired a new position in Intuitive Surgical in the 3rd quarter valued at approximately $558,807,000. Proficio Capital Partners LLC increased its position in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after acquiring an additional 948,902 shares during the period. FMR LLC increased its position in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the period. Raymond James Financial Inc. acquired a new position in Intuitive Surgical in the 4th quarter valued at approximately $313,769,000. Finally, Wilmington Savings Fund Society FSB increased its position in Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after acquiring an additional 552,058 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Evercore ISI increased their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Truist Financial increased their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Bernstein Bank increased their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Finally, Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $484.44 on Friday. The company’s fifty day moving average price is $567.46 and its 200-day moving average price is $531.60. The firm has a market capitalization of $172.55 billion, a price-to-earnings ratio of 75.58, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 33,754 shares of company stock valued at $17,691,621. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.